Diagnosticos da America S.A.Diagnosticos da America S.A.Diagnosticos da America S.A.

Diagnosticos da America S.A.

No trades
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪5.19 B‬BRL
−0.82BRL
‪−1.20 B‬BRL
‪15.32 B‬BRL
‪299.87 M‬
Beta (1Y)
1.75

About Diagnosticos da America S.A.


CEO
Lício Cintra
Headquarters
Barueri
Founded
1966
IPO date
Nov 19, 2004
Identifiers
2
ISIN BRDASAACNOR1
Diagnósticos da América SA engages in medical diagnostics services and in the business of research and development of diagnostic tests and their application to the medical practice. It services include clinical analysis, diagnostic imaging, and genomic medicine. The company was founded by Humberto Delboni Filho and Raul Dias dos Santos on July 7, 1966 and is headquartered in Barueri, Brazil.

Check out other big names from the same industry as DASA3F.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of DASA3F is 4.15 BRL — it hasn't changed in the past 24 hours. Watch Diagnosticos da America S.A. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMFBOVESPA exchange Diagnosticos da America S.A. stocks are traded under the ticker DASA3F.
DASA3F stock has fallen by −2.09% compared to the previous week, the month change is a 5.78% rise, over the last year Diagnosticos da America S.A. has showed a 131.84% increase.
We've gathered analysts' opinions on Diagnosticos da America S.A. future price: according to them, DASA3F price has a max estimate of 6.00 BRL and a min estimate of 1.00 BRL. Watch DASA3F chart and read a more detailed Diagnosticos da America S.A. stock forecast: see what analysts think of Diagnosticos da America S.A. and suggest that you do with its stocks.
DASA3F reached its all-time high on Jan 19, 2021 with the price of 290.00 BRL, and its all-time low was 1.19 BRL and was reached on Jul 30, 2025. View more price dynamics on DASA3F chart.
See other stocks reaching their highest and lowest prices.
DASA3F stock is 3.44% volatile and has beta coefficient of 1.75. Track Diagnosticos da America S.A. stock price on the chart and check out the list of the most volatile stocks — is Diagnosticos da America S.A. there?
Today Diagnosticos da America S.A. has the market capitalization of ‪5.15 B‬, it has decreased by −1.63% over the last week.
Yes, you can track Diagnosticos da America S.A. financials in yearly and quarterly reports right on TradingView.
Diagnosticos da America S.A. is going to release the next earnings report on Mar 26, 2026. Keep track of upcoming events with our Earnings Calendar.
DASA3F earnings for the last quarter are 0.07 BRL per share, whereas the estimation was −0.08 BRL resulting in a 190.49% surprise. The estimated earnings for the next quarter are −0.11 BRL per share. See more details about Diagnosticos da America S.A. earnings.
Diagnosticos da America S.A. revenue for the last quarter amounts to ‪2.61 B‬ BRL, despite the estimated figure of ‪2.53 B‬ BRL. In the next quarter, revenue is expected to reach ‪2.39 B‬ BRL.
DASA3F net income for the last quarter is ‪95.81 M‬ BRL, while the quarter before that showed ‪−178.59 M‬ BRL of net income which accounts for 153.65% change. Track more Diagnosticos da America S.A. financial stats to get the full picture.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Diagnosticos da America S.A. EBITDA is ‪2.19 B‬ BRL, and current EBITDA margin is 15.49%. See more stats in Diagnosticos da America S.A. financial statements.
Like other stocks, DASA3F shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Diagnosticos da America S.A. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Diagnosticos da America S.A. technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Diagnosticos da America S.A. stock shows the neutral signal. See more of Diagnosticos da America S.A. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.